<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(7)</volume><submitter>Chen W</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To investigate the role of nucleoside diphosphate kinase 2 (NME2) in HCC progression, assessing its therapeutic potential.&lt;h4>Methods&lt;/h4>Utilizing transcriptome sequencing data from The Cancer Genome Atlas (TCGA) and immunohistochemical staining of tissue microarrays, we analyzed NME2 expression in HCC tumor tissues. The effects of NME2 on HCC cell proliferation and autophagy flux were assessed through knockdown and overexpression experiments. Additionally, the relationship between NME2 and 4EBP1 phosphorylation was explored through specific site mutation analysis.&lt;h4>Results&lt;/h4>NME2 overexpression in HCC correlated with poor prognosis. NME2 knockdown significantly hindered HCC cell proliferation and induced autophagy flux. Notably, NME2 modulates 4EBP1 phosphorylation</pubmed_abstract><journal>Hepatology communications</journal><pagination>e0715</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12150935</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR.</pubmed_title><pmcid>PMC12150935</pmcid><pubmed_authors>Zhou DC</pubmed_authors><pubmed_authors>Rui CH</pubmed_authors><pubmed_authors>Shan SL</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Liu FB</pubmed_authors><pubmed_authors>Hou H</pubmed_authors><pubmed_authors>Chen JM</pubmed_authors><pubmed_authors>Luo WW</pubmed_authors></additional><is_claimable>false</is_claimable><name>NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR.</name><description>&lt;h4>Background&lt;/h4>To investigate the role of nucleoside diphosphate kinase 2 (NME2) in HCC progression, assessing its therapeutic potential.&lt;h4>Methods&lt;/h4>Utilizing transcriptome sequencing data from The Cancer Genome Atlas (TCGA) and immunohistochemical staining of tissue microarrays, we analyzed NME2 expression in HCC tumor tissues. The effects of NME2 on HCC cell proliferation and autophagy flux were assessed through knockdown and overexpression experiments. Additionally, the relationship between NME2 and 4EBP1 phosphorylation was explored through specific site mutation analysis.&lt;h4>Results&lt;/h4>NME2 overexpression in HCC correlated with poor prognosis. NME2 knockdown significantly hindered HCC cell proliferation and induced autophagy flux. Notably, NME2 modulates 4EBP1 phosphorylation</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-06-08T06:51:40.468Z</modification><creation>2026-06-08T03:14:37.377Z</creation></dates><accession>S-EPMC12150935</accession><cross_references><pubmed>40489759</pubmed><doi>10.1097/HC9.0000000000000715</doi></cross_references></HashMap>